Jubilant Ingrevia Ltd
NSE:JUBLINGREA

Watchlist Manager
Jubilant Ingrevia Ltd Logo
Jubilant Ingrevia Ltd
NSE:JUBLINGREA
Watchlist
Price: 680.85 INR 1.68% Market Closed
Market Cap: 108.4B INR
Have any thoughts about
Jubilant Ingrevia Ltd?
Write Note

Intrinsic Value

The intrinsic value of one JUBLINGREA stock under the Base Case scenario is 501.18 INR. Compared to the current market price of 680.85 INR, Jubilant Ingrevia Ltd is Overvalued by 26%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

JUBLINGREA Intrinsic Value
501.18 INR
Overvaluation 26%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Jubilant Ingrevia Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for JUBLINGREA cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about JUBLINGREA?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Jubilant Ingrevia Ltd

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Jubilant Ingrevia Ltd

Provide an overview of the primary business activities
of Jubilant Ingrevia Ltd.

What unique competitive advantages
does Jubilant Ingrevia Ltd hold over its rivals?

What risks and challenges
does Jubilant Ingrevia Ltd face in the near future?

Has there been any significant insider trading activity
in Jubilant Ingrevia Ltd recently?

Summarize the latest earnings call
of Jubilant Ingrevia Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Jubilant Ingrevia Ltd.

Provide P/S
for Jubilant Ingrevia Ltd.

Provide P/E
for Jubilant Ingrevia Ltd.

Provide P/OCF
for Jubilant Ingrevia Ltd.

Provide P/FCFE
for Jubilant Ingrevia Ltd.

Provide P/B
for Jubilant Ingrevia Ltd.

Provide EV/S
for Jubilant Ingrevia Ltd.

Provide EV/GP
for Jubilant Ingrevia Ltd.

Provide EV/EBITDA
for Jubilant Ingrevia Ltd.

Provide EV/EBIT
for Jubilant Ingrevia Ltd.

Provide EV/OCF
for Jubilant Ingrevia Ltd.

Provide EV/FCFF
for Jubilant Ingrevia Ltd.

Provide EV/IC
for Jubilant Ingrevia Ltd.

Show me price targets
for Jubilant Ingrevia Ltd made by professional analysts.

What are the Revenue projections
for Jubilant Ingrevia Ltd?

How accurate were the past Revenue estimates
for Jubilant Ingrevia Ltd?

What are the Net Income projections
for Jubilant Ingrevia Ltd?

How accurate were the past Net Income estimates
for Jubilant Ingrevia Ltd?

What are the EPS projections
for Jubilant Ingrevia Ltd?

How accurate were the past EPS estimates
for Jubilant Ingrevia Ltd?

What are the EBIT projections
for Jubilant Ingrevia Ltd?

How accurate were the past EBIT estimates
for Jubilant Ingrevia Ltd?

Compare the revenue forecasts
for Jubilant Ingrevia Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Jubilant Ingrevia Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Jubilant Ingrevia Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Jubilant Ingrevia Ltd compared to its peers.

Compare the P/E ratios
of Jubilant Ingrevia Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Jubilant Ingrevia Ltd with its peers.

Analyze the financial leverage
of Jubilant Ingrevia Ltd compared to its main competitors.

Show all profitability ratios
for Jubilant Ingrevia Ltd.

Provide ROE
for Jubilant Ingrevia Ltd.

Provide ROA
for Jubilant Ingrevia Ltd.

Provide ROIC
for Jubilant Ingrevia Ltd.

Provide ROCE
for Jubilant Ingrevia Ltd.

Provide Gross Margin
for Jubilant Ingrevia Ltd.

Provide Operating Margin
for Jubilant Ingrevia Ltd.

Provide Net Margin
for Jubilant Ingrevia Ltd.

Provide FCF Margin
for Jubilant Ingrevia Ltd.

Show all solvency ratios
for Jubilant Ingrevia Ltd.

Provide D/E Ratio
for Jubilant Ingrevia Ltd.

Provide D/A Ratio
for Jubilant Ingrevia Ltd.

Provide Interest Coverage Ratio
for Jubilant Ingrevia Ltd.

Provide Altman Z-Score Ratio
for Jubilant Ingrevia Ltd.

Provide Quick Ratio
for Jubilant Ingrevia Ltd.

Provide Current Ratio
for Jubilant Ingrevia Ltd.

Provide Cash Ratio
for Jubilant Ingrevia Ltd.

What is the historical Revenue growth
over the last 5 years for Jubilant Ingrevia Ltd?

What is the historical Net Income growth
over the last 5 years for Jubilant Ingrevia Ltd?

What is the current Free Cash Flow
of Jubilant Ingrevia Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Jubilant Ingrevia Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Jubilant Ingrevia Ltd

Current Assets 17.8B
Cash & Short-Term Investments 1.2B
Receivables 5.8B
Other Current Assets 10.9B
Non-Current Assets 29.5B
Long-Term Investments 304m
PP&E 28.5B
Intangibles 204.3m
Other Non-Current Assets 515.3m
Current Liabilities 12.9B
Accounts Payable 7.7B
Short-Term Debt 3.1B
Other Current Liabilities 2.1B
Non-Current Liabilities 7.1B
Long-Term Debt 4.3B
Other Non-Current Liabilities 2.8B
Efficiency

Earnings Waterfall
Jubilant Ingrevia Ltd

Revenue
40.9B INR
Cost of Revenue
-24.7B INR
Gross Profit
16.2B INR
Operating Expenses
-13.5B INR
Operating Income
2.7B INR
Other Expenses
-972.1m INR
Net Income
1.7B INR

Free Cash Flow Analysis
Jubilant Ingrevia Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

Jubilant Ingrevia reported sequential growth in Q1 FY '25, driven by improvements in Specialty Chemicals, which saw EBITDA rise by 50% YoY. The overall revenue was INR 1,024 crores, slightly down from INR 1,075 crores YoY, mainly due to a drop in Chemical Intermediates. The company’s net debt stood at INR 677 crores. The nutrition segment improved, with a 165% QoQ EBITDA growth. The firm reaffirmed its goal for 3x revenue and 4x EBITDA in five years, targeting 20%-plus EBITDA margins. They also noted the completion of their new FDA-inspected manufacturing facility with zero observations.

What is Earnings Call?
Fundamental Scores

JUBLINGREA Profitability Score
Profitability Due Diligence

Jubilant Ingrevia Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Revenue Growth Forecast
Positive 3-Year Average ROE
Positive 3-Year Average ROIC
50/100
Profitability
Score

Jubilant Ingrevia Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

JUBLINGREA Solvency Score
Solvency Due Diligence

Jubilant Ingrevia Ltd's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Low D/E
High Altman Z-Score
Long-Term Solvency
Short-Term Solvency
50/100
Solvency
Score

Jubilant Ingrevia Ltd's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

JUBLINGREA Price Targets Summary
Jubilant Ingrevia Ltd

Wall Street analysts forecast JUBLINGREA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for JUBLINGREA is 728.96 INR with a low forecast of 606 INR and a high forecast of 891.45 INR.

Lowest
Price Target
606 INR
11% Downside
Average
Price Target
728.96 INR
7% Upside
Highest
Price Target
891.45 INR
31% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for JUBLINGREA?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for JUBLINGREA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

JUBLINGREA Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Jubilant Ingrevia Ltd Logo
Jubilant Ingrevia Ltd

Country

India

Industry

Chemicals

Market Cap

107.6B INR

Dividend Yield

0.73%

Description

Jubilant Ingrevia Ltd. manufactures chemical products. The company is headquartered in Noida, Uttar Pradesh. The company went IPO on 2021-03-19. The firm offers a broad portfolio of ingredients that find application in a range of industries. Its business is focused on three core segments: Speciality Chemicals, Nutrition and Health Solutions, and Life Science Chemicals. The Speciality Chemicals businesses is organized across four verticals: Speciality Ingredients, Fine Chemicals, Crop Protection Chemicals, and custom development and manufacturing (CDMO). The Nutrition & Health Solutions segment comprises of Nutrition & Health Ingredients, Animal Nutrition & Health Solutions, and Human Nutrition & Health Solutions segments. The Life Science Chemicals is focused on acetyls and alcohol derivatives, which includes products, such as acetic anhydride, ethyl acetate, anhydrous alcohol, acetaldehyde, formaldehyde and propionic anhydride. The firm is focused on serving pharmaceutical, nutrition, agrochemical, consumer and industrial customers.

Contact

UTTAR PRADESH
Noida
1A, Sector 16A
+911204361000
jubilantingrevia.com

IPO

2021-03-19

Employees

2 064

Officers

Co-Chairman & Whole-Time Director
Mr. Hari Shanker Bhartia B.E., B.Tech
Co-CEO & Whole-time Director
Mr. Chandan Singh Sengar B.Sc., BSc., M.B.A., MBA
CEO, MD & Director
Mr. Deepak Jain
Company Secretary & Compliance Officer
Ms. Deepanjali Gulati
President & CFO
Mr. Varun Gupta
President of Operations
Mr. Vijay Kumar Srivastava
Show More
Executive VP & Head of Legal
Mr. Sanjay Gupta A.C.M.A., B.Com., L.L.B.
Senior VP & Head of Human Resources
Ms. Vinita Koul
President of Nutrition & Health Solutions
Mr. Ramamurthi Kumar CWA, MBA
President & Head of Supply Chain
Mr. Prasad Vasant Joglekar
Show Less

See Also

Discover More
What is the Intrinsic Value of one JUBLINGREA stock?

The intrinsic value of one JUBLINGREA stock under the Base Case scenario is 501.18 INR.

Is JUBLINGREA stock undervalued or overvalued?

Compared to the current market price of 680.85 INR, Jubilant Ingrevia Ltd is Overvalued by 26%.

Back to Top